Inhibition of activin signaling in lung adenocarcinoma increases the therapeutic index of platinum chemotherapy

Journal: Science Translational Medicine

Published: 2018-07-25

DOI: 10.1126/scitranslmed.aat3504

Affiliations: 18

Authors: 33

Go to article
Institutions FC
Hudson Institute of Medical Research, Australia 0.25
The Kinghorn Cancer Centre (TKCC), Australia 0.22
Paranta Biosciences Limited, Australia 0.10
Faculty of Medicine, Nursing and Health Sciences, Monash University, Australia 0.10
UCSF Department of Pediatrics, United States of America (USA) 0.09
Monash Medical Centre (MMC), Australia 0.06
St Vincent's Clinical School (STVCS), UNSW, Australia 0.05
Queen Elizabeth II Medical Centre (QEIIMC), UWA, Australia 0.03
St Vincent's Hospital Sydney, Australia 0.02
ANZAC Research Institute, Australia 0.02
University of Melbourne Centre for Cancer Research (UMCCR), UniMelb, Australia 0.02
Australian Regenerative Medicine Institute (ARMI), Monash University, Australia 0.02
Department of Anatomy and Developmental Biology, Monash University, Australia 0.02
UCD School of Medicine and Medical Science (UCD Medicine), Ireland 0.01
MOE Key Laboratory of Carcinogenesis and Translational Research, PKU, China 0.01
Centre for Cancer Bioinformatics, PKU, China 0.01